x
Fluart

  • 2097 Pilisborosjenő, Fő utca 7, Hungary
  • info[at]fluart.hu
Fluart
    • MagyarMagyar
    • EnglishEnglish
  • info[at]fluart.hu
  • 2097 Pilisborosjenő, Fő utca 7, Hungary
  • About us
    • Company profile
    • Leaders
    • Product portfolio
    • Research & Development
    • Company sites
    • Mission and Vision
    • Certificates
  • Services
    • Contract manufacturing
    • Technology transfer
    • References
  • Publications
  • Grants and results
  • Sustainability
    • Environment and health safety
    • Renewable energy
    • Code of ethics
    • Social responsibility
    • Education and training
  • Job offers
  • Contact
    • Suspected adverse drug reaction reporting
    • Legal statement
    • Data Protection
    • Transparency
Logo
  • MagyarMagyar
  • EnglishEnglish

Our vaccine products meet all required efficacy criteria set forth in national and international standards and requirements.

3Fluart seasonal influenza vaccine (whole virion, inactivated, adjuvanted):
Since the influenza season of 2015/16 Fluart introduced to the market a brand-new development seasonal flu vaccine, the 3Fluart with lowered active ingredient (6 micrograms/strain) replacing previous 15 micrograms product FluvalAB.

1Fluart (H1N1 pandemic) influenza vaccine (formerly called Fluval P (H1N1) pandemic influenza vaccine; whole virion, inactivated, adjuvanted
Fluart produced its Fluval P (H1N1 pandemic) vaccine in large quantities (6.5 million doses compared to the population of Hungary, which is 10 million people) during the H1N1 pandemic in 2009. The vaccine was characterized by low active ingredient content (6µg HA).

Over 35 million doses of seasonal and pandemic influenza vaccines have been produced and administered so far.

töltőgép
IMG_20230620_103123
IMG_20230620_102919
IMG_20230620_103220
termosztát

Fluart Innovative Vaccines Kft.